Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 3
2022 1
2023 1
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean vila v (120 results)?
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study.
Korotych O, Achar J, Gurbanova E, Hovhannesyan A, Lomtadze N, Ciobanu A, Skrahina A, Dravniece G, Kuksa L, Rich M, Khachatryan N, Germanovych M, Kadyrov A, Terleieva I, Akhundova I, Adenov M, Durdyeva M, Kiria N, Parpieva N, Yatskevich N, Jumayev R, Nurov R, Diktanas S, Vilc V, Migliori GB, Yedilbayev A. Korotych O, et al. Among authors: vilc v. Lancet Infect Dis. 2024 Oct;24(10):1151-1161. doi: 10.1016/S1473-3099(24)00228-7. Epub 2024 Jun 13. Lancet Infect Dis. 2024. PMID: 38880112 Free PMC article.
Building a tuberculosis-free world: The Lancet Commission on tuberculosis.
Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP. Reid MJA, et al. Among authors: vilc v. Lancet. 2019 Mar 30;393(10178):1331-1384. doi: 10.1016/S0140-6736(19)30024-8. Epub 2019 Mar 20. Lancet. 2019. PMID: 30904263 Review. No abstract available.
What is behind programmatic treatment outcome definitions for tuberculosis?
Avaliani Z, Gozalov O, Kuchukhidze G, Skrahina A, Soltan V, van den Boom M, Vasilyeva I, Vilc V, Yedilbayev A. Avaliani Z, et al. Among authors: vilc v. Eur Respir J. 2020 Jul 23;56(1):2001751. doi: 10.1183/13993003.01751-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32703821 Free article. No abstract available.
Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases.
Valiulis A, Bousquet J, Veryga A, Suprun U, Sergeenko D, Cebotari S, Borelli D, Pietikainen S, Banys J, Agache I, Billo NE, Bush A, Chkhaidze I, Dubey L, Fokkens WJ, Grigg J, Haahtela T, Julge K, Katilov O, Khaltaev N, Odemyr M, Palkonen S, Savli R, Utkus A, Vilc V, Alasevicius T, Bedbrook A, Bewick M, Chorostowska-Wynimko J, Danila E, Hadjipanayis A, Karseladze R, Kvedariene V, Lesinskas E, Münter L, Samolinski B, Sargsyan S, Sitkauskiene B, Somekh D, Vaideliene L, Valiulis A, Hellings PW. Valiulis A, et al. Among authors: vilc v. Clin Transl Allergy. 2019 Jan 28;9:7. doi: 10.1186/s13601-019-0242-2. eCollection 2019. Clin Transl Allergy. 2019. PMID: 30705747 Free PMC article. Review.
Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial.
Rosu L, Madan JJ, Tomeny EM, Muniyandi M, Nidoi J, Girma M, Vilc V, Bindroo P, Dhandhukiya R, Bayissa AK, Meressa D, Narendran G, Solanki R, Bhatnagar AK, Tudor E, Kirenga B, Meredith SK, Nunn AJ, Bronson G, Rusen ID, Squire SB, Worrall E; STREAM Study Health Economic Evaluation Collaborators. Rosu L, et al. Among authors: vilc v. Lancet Glob Health. 2023 Feb;11(2):e265-e277. doi: 10.1016/S2214-109X(22)00498-3. Epub 2022 Dec 21. Lancet Glob Health. 2023. PMID: 36565704 Free article. Clinical Trial.
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.
Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L, Calò Carducci FI, Gabrovska N, Velizarova S, Prunk P, Osterman V, Krivec U, Lo Vecchio A, Shingadia D, Soriano-Arandes A, Melendo S, Lanari M, Pierantoni L, Wagner N, L'Huillier AG, Heininger U, Ritz N, Bandi S, Krajcar N, Roglić S, Santos M, Christiaens C, Creuven M, Buonsenso D, Welch SB, Bogyi M, Brinkmann F, Tebruegge M; ptbnet COVID-19 Study Group. Götzinger F, et al. Lancet Child Adolesc Health. 2020 Sep;4(9):653-661. doi: 10.1016/S2352-4642(20)30177-2. Epub 2020 Jun 25. Lancet Child Adolesc Health. 2020. PMID: 32593339 Free PMC article.
Assessing tuberculosis control priorities in high-burden settings: a modelling approach.
Vesga JF, Hallett TB, Reid MJA, Sachdeva KS, Rao R, Khaparde S, Dave P, Rade K, Kamene M, Omesa E, Masini E, Omale N, Onyango E, Owiti P, Karanja M, Kiplimo R, Alexandru S, Vilc V, Crudu V, Bivol S, Celan C, Arinaminpathy N. Vesga JF, et al. Among authors: vilc v. Lancet Glob Health. 2019 May;7(5):e585-e595. doi: 10.1016/S2214-109X(19)30037-3. Epub 2019 Mar 20. Lancet Glob Health. 2019. PMID: 30904521 Free article.
Perspectives on multisectoral accountability framework to end tuberculosis in the Eastern Europe and Central Asia region: a mixed-methods study.
Chorna Y, Lukash IG, Kalancha Y, Tonkonoh L, Abdullaeva M, Adenov M, Chuprynska M, Hasanova S, Ibragimova O, Jazybekova P, Kamenska N, Klymenko O, Koroieva I, Kravets L, Kryshtafovych N, Pirtina L, Skrahina A, Terleeva Y, Vilc V, Zakrevska H, Zhurkin D, Malar J, Daftary A. Chorna Y, et al. Among authors: vilc v. BMC Glob Public Health. 2025 Mar 5;3(1):20. doi: 10.1186/s44263-025-00136-y. BMC Glob Public Health. 2025. PMID: 40045393 Free PMC article.
Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova.
Allel K, Palmer T, Abou Jaoude GJ, Korotych O, Yedilbayev A, Vilc V, Corloteanu A, Macari M, Evghenia C, Laticevschi D, Shakhimurat-Shaimovich I, Anar-Saduakasovna R, Gulzhan-Elbrusovna T, Anatolievna-Ryazanet D, Shahrizada-Yergalymovna A, Yatskevich N, Skrahina A, Zhurkin D, Avaliani Z, Kiria N, Lomtadze N, Kiria N, Avaliani T, Khonelidze I, Danelia M, Maxim C, Haghparast-Bidgoli H, Skordis J. Allel K, et al. Among authors: vilc v. BMJ Glob Health. 2025 Nov 8;10(11):e018099. doi: 10.1136/bmjgh-2024-018099. BMJ Glob Health. 2025. PMID: 41206134 Free PMC article.
11 results